TY  - JOUR
AU  - Gómez-Bastero Fernández, Ana
AU  - Medina Gallardo, Juan Francisco
AU  - Delgado Romero, Julio
AU  - Romero Falcón, Auxiliadora
AU  - Benito Bernáldez, Cristina
AU  - Gallego Borrego, Javier
AU  - Álvarez-Gutiérrez, Francisco Javier
PY  - 2022
DO  - 10.2147/JAA.S358705
SN  - 1178-6965
UR  - http://hdl.handle.net/10668/20469
T2  - Journal of asthma and allergy
AB  - Benralizumab is a monoclonal antibody that targets the α subunit of the IL-5 receptor. Clinical trials have demonstrated the efficacy of this agent with respect to lung function and symptom control in patients with refractory eosinophilic asthma....
LA  - en
KW  - daily clinical practice
KW  - monoclonal antibodies
KW  - severe uncontrolled asthma
KW  - treatment optimization
TI  - Effectiveness of Switching to Benralizumab in Severe Refractory Eosinophilic Asthma.
TY  - research article
VL  - 15
ER  -